Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation*

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Medical Research and Opinion

• Publication date

  2006-03-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/030079906X96281PMID 16684430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The American Psychiatric Association

  2005cited by this paper
• Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.

  2003cited by this paper
• Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

  2001cited by this paper
• Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

  2001cited by this paper
• Treatment of epilepsy in the multiply handicapped.

  2000cited by this paper
• Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.

  2000cited by this paper
• A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

  1999cited by this paper
• Lamotrigine Monotherapy in Newly Diagnosed Untreated Epilepsy: A Double‐Blind Comparison with Phenytoin

  1999cited by this paper
• Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children

  1999cited by this paper
• Safety Review of Adult Clinical Trial Experience with Lamotrigine

  1998cited by this paper
• Lamotrigine in Multihandicapped Therapy-Resistant Epileptic Patients

  1998cited by this paper
• An active-control trial of lamotrigine monotherapy for partial seizures

  1998cited by this paper
• Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.

  1998cited by this paper
• Lamotrigine in Rett syndrome: Treatment experience from a pilot study

  1998cited by this paper
• Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.

  1997cited by this paper
• Meeting the Challenge of Epilepsy in Persons With Multiple Handicaps

  1997cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome.

  1997cited by this paper
• Comprehensive Management of Epilepsy in Persons with Mental Retardation

  1997cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

  1997cited by this paper
• Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

  1995cited by this paper
• The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.

  1995cited by this paper
• Lamotrigine in infantile spasms.

  1994cited by this paper
• Intractable Epilepsy in Children. The Efficacy of Lamotrigine Treatment, Including Non-Seizure-Related Benefits

  1994cited by this paper
• Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy

  1993cited by this paper
• Antiepileptic drug status in adult outpatients with mental retardation.

  1993cited by this paper
• Epilepsy and mental retardation: an overview.

  1993cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group.

  1993cited by this paper
• Lamotrigine in Rett syndrome.

  1993cited by this paper
• Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures

  1993cited by this paper
• Results of Antiepileptic Drug Reduction in Patients with Multiple Handicaps and Epilepsy

  1993cited by this paper
• Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome.

  1992cited by this paper
• Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation

  1992cited by this paper
• A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.

  1990cited by this paper
• A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures.

  1990cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper
• Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial Seizures

  1989cited by this paper
• Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions.

  1987cited by this paper
• Determinants of community placement of institutionalized mentally retarded persons.

  1983cited by this paper
• Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures

  1981cited by this paper

• Evaluation of the Effects of Clobazam on Seizure Control and Quality of Life in Children With Lennox-Gastaut Syndrome: A Pilot Study

  2019cites this paper
• Measurement of side effects of anti-epileptic drugs (AEDs) in adults with intellectual disability: A systematic review.

  2017influential citation
• Antiepileptika – Besonderheiten bei Menschen mit geistiger Behinderung

  2017influential citation
• A Practitioner’s Guide to Prescribing Lamotrigine for Adults with Intellectual Disabilities

  2012cites this paper
• Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.

  2009cites this paper
• Co-morbidity of psychiatric disorder and medical illness in people with intellectual disabilities

  2007cites this paper